Arcadia Biosciences, Inc. — Director's Dealing 2020

Apr 3, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2020-04-01

Reporting Person: Shultz Randall (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12300	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.00	2029-04-08	Common Stock (15000)		Direct
Stock Option (Right to Buy)	$4.91	2030-02-03	Common Stock (27000)		Direct

Footnotes

F1: The options were granted on 4/8/2019 and the vesting occurs as follows: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

F2: The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.